BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cacicedo J, Navarro A, Del Hoyo O, Gomez-Iturriaga A, Alongi F, Medina JA, Elicin O, Skanjeti A, Giammarile F, Bilbao P, Casquero F, de Bari B, Dal Pra A. Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist. Br J Radiol 2016;89:20160217. [PMID: 27416996 DOI: 10.1259/bjr.20160217] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
Number Citing Articles
1 Wiggins RH, Hoffman JM, Fine GC, Covington MF, Salem AE, Koppula BR, Morton KA. PET-CT in Clinical Adult Oncology-V. Head and Neck and Neuro Oncology. Cancers (Basel) 2022;14:2726. [PMID: 35681709 DOI: 10.3390/cancers14112726] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kandathil A, Subramaniam RM. PET/Computed Tomography. PET Clinics 2022. [DOI: 10.1016/j.cpet.2021.12.009] [Reference Citation Analysis]
3 Maajem M, Leclère J, Bourhis D, Tissot V, Icard N, Arnaud L, Le Pennec R, Dissaux G, Gujral DM, Salaün P, Schick U, Abgral R. Comparison of Volumetric Quantitative PET Parameters Before and After a CT-Based Elastic Deformation on Dual-Time 18FDG-PET/CT Images: A Feasibility Study in a Perspective of Radiotherapy Planning in Head and Neck Cancer. Front Med 2022;9:831457. [DOI: 10.3389/fmed.2022.831457] [Reference Citation Analysis]
4 Minamitake A, Murakami R, Shiraishi S, Yoshida R, Sakata J, Hirosue A, Kawahara K, Yamana K, Nakayama H, Kitajima M, Sakamoto F. Laterality on FDG-PET/CT in clinically node-negative early-stage oral squamous cell carcinoma: a retrospective analysis of patients with late neck metastasis. Oral Radiol 2022. [PMID: 35088222 DOI: 10.1007/s11282-021-00581-z] [Reference Citation Analysis]
5 Lekanne Dit Deprez LW, Morand GB, Thüring C, Pazahr S, Hüllner MW, Broglie MA. SUVmax for predicting regional control in oropharyngeal cancer. Eur Arch Otorhinolaryngol 2021. [PMID: 34779928 DOI: 10.1007/s00405-021-07169-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Elicin O, Vollnberg B, Shelan M, Riggenbach E, Bojaxhiu B, Mathier E, Giger R, Aebersold DM, Klaeser B. Impact of pretreatment second look 18FDG-PET/CT on stage and treatment changes in head and neck cancer. Clin Transl Radiat Oncol 2021;31:8-13. [PMID: 34504959 DOI: 10.1016/j.ctro.2021.08.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Garau LM, Manca G, Bola S, Aringhieri G, Faggioni L, Volterrani D. Correlation between 18F-FDG PET/CT and diffusion-weighted MRI parameters in head and neck squamous cell carcinoma at baseline and after chemo-radiotherapy. A retrospective single institutional study. Oral Radiol 2021. [PMID: 34133000 DOI: 10.1007/s11282-021-00545-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Sideras P, Singh G. MRI Dynamic Contrast Imaging of Oral Cavity and Oropharyngeal Tumors. Top Magn Reson Imaging 2021;30:97-104. [PMID: 33828061 DOI: 10.1097/RMR.0000000000000283] [Reference Citation Analysis]
9 Barua S, Elhalawani H, Volpe S, Al Feghali KA, Yang P, Ng SP, Elgohari B, Granberry RC, Mackin DS, Gunn GB, Hutcheson KA, Chambers MS, Court LE, Mohamed ASR, Fuller CD, Lai SY, Rao A. Computed Tomography Radiomics Kinetics as Early Imaging Correlates of Osteoradionecrosis in Oropharyngeal Cancer Patients. Front Artif Intell 2021;4:618469. [PMID: 33898983 DOI: 10.3389/frai.2021.618469] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Minamitake A, Murakami R, Sakamoto F, Yoshida R, Sakata J, Hirosue A, Kawahara K, Yamana K, Nakayama H, Toya R, Shiraishi S. Can MRI-derived depth of invasion predict nodal recurrence in oral tongue cancer? Oral Radiol 2021. [PMID: 33469800 DOI: 10.1007/s11282-020-00505-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Tustumi F, Duarte PS, Albenda DG, Takeda FR, Sallum RAA, Junior UR, Buchpiguel CA, Cecconello I. Prognostic value of 18F-fluorodeoxyglucose PET/computed tomography metabolic parameters measured in the primary tumor and suspicious lymph nodes before neoadjuvant therapy in patients with esophageal carcinoma. Nucl Med Commun 2021;42:437-43. [PMID: 33306638 DOI: 10.1097/MNM.0000000000001347] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
12 Grunert M, Prasad V. PET-basierte Bestrahlungsplanung. Radiopraxis 2020;13:E80-E97. [DOI: 10.1055/a-1218-5129] [Reference Citation Analysis]
13 Lang D, Wahl G, Poier N, Graf S, Kiesl D, Lamprecht B, Gabriel M. Impact of PET/CT for Assessing Response to Immunotherapy-A Clinical Perspective. J Clin Med 2020;9:E3483. [PMID: 33126715 DOI: 10.3390/jcm9113483] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
14 Barua S, Elhalawani H, Volpe S, Feghali KA, Yang P, Ng SP, Elgohari B, Granberry RC, Mackin DS, Gunn GB, Hutcheson KA, Chambers MS, Court LE, Mohamed A, Fuller CD, Lai SY, Rao A. Discovering early imaging biomarkers of osteoradionecrosis in oropharyngeal cancer by characterization of temporal changes in computed tomography mandibular radiomic features.. [DOI: 10.1101/2020.10.09.20208827] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Xu Y, Zhang Y, Xu Z, Liu S, Xu G, Gao L, Luo J, Huang X, Wang K, Qu Y, Zhang S, Liu Q, Wu R, Chen X, Yi J. Patterns of Cervical Lymph Node Metastasis in Locally Advanced Supraglottic Squamous Cell Carcinoma: Implications for Neck CTV Delineation. Front Oncol 2020;10:1596. [PMID: 32984023 DOI: 10.3389/fonc.2020.01596] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
16 Strohl MP, Ha PK, Flavell RR, Yom SS. PET/CT in Surgical Planning for Head and Neck Cancer. Semin Nucl Med 2021;51:50-8. [PMID: 33246539 DOI: 10.1053/j.semnuclmed.2020.07.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
17 Vidiri A, Gangemi E, Ruberto E, Pasqualoni R, Sciuto R, Sanguineti G, Farneti A, Benevolo M, Rollo F, Sperati F, Spasiano F, Pellini R, Marzi S. Correlation between histogram-based DCE-MRI parameters and 18F-FDG PET values in oropharyngeal squamous cell carcinoma: Evaluation in primary tumors and metastatic nodes. PLoS One 2020;15:e0229611. [PMID: 32119697 DOI: 10.1371/journal.pone.0229611] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
18 Krdzalic J, Versleijen M, Maas M. N-stage Challenges. Imaging and Interventional Radiology for Radiation Oncology 2020. [DOI: 10.1007/978-3-030-38261-2_17] [Reference Citation Analysis]
19 Chen WY, Chen TC, Lai SF, Liang TH, Huang BS, Wang CW. Outcome of bimodality definitive chemoradiation does not differ from that of trimodality upfront neck dissection followed by adjuvant treatment for >6 cm lymph node (N3) head and neck cancer. PLoS One 2019;14:e0225962. [PMID: 31794576 DOI: 10.1371/journal.pone.0225962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Moan JM, Amdal CD, Malinen E, Svestad JG, Bogsrud TV, Dale E. The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status. Radiotherapy and Oncology 2019;140:54-61. [DOI: 10.1016/j.radonc.2019.05.019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
21 Elicin O, Putora PM, Siano M, Broglie MA, Simon C, Zwahlen D, Huber GF, Ballerini G, Beffa L, Giger R, Rothschild S, Negri SV, Dulguerov P, Henke G. A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 2 (Radiation Oncology). Front Oncol 2019;9:1126. [PMID: 31709186 DOI: 10.3389/fonc.2019.01126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
22 Nøhr A, Gram SB, Charabi B, Tvedskov JF, Wessel I, Friborg J, Håkansson K, von Buchwald C, Fischer BM, Rasmussen JH. PET/CT prior to salvage surgery in recurrent head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 2019;276:2895-902. [DOI: 10.1007/s00405-019-05550-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Mirus M, Tokalov SV, Abramyuk A, Heinold J, Prochnow V, Zöphel K, Kotzerke J, Abolmaali N. Noninvasive assessment and quantification of tumor vascularization using [18F]FDG-PET/CT and CE-CT in a tumor model with modifiable angiogenesis-an animal experimental prospective cohort study. EJNMMI Res 2019;9:55. [PMID: 31227938 DOI: 10.1186/s13550-019-0502-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
24 Chotchutipan T, Rosen BS, Hawkins PG, Lee JY, Saripalli AL, Thakkar D, Eisbruch A, El Naqa I, Mierzwa ML. Volumetric 18 F-FDG-PET parameters as predictors of locoregional failure in low-risk HPV-related oropharyngeal cancer after definitive chemoradiation therapy. Head Neck 2019;41:366-73. [PMID: 30548704 DOI: 10.1002/hed.25505] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
25 Okazaki E, Kawabe J, Oishi M, Hosono M, Higashiyama S, Teranishi Y, Shiomi S, Iguchi H, Miki Y. Prognostic significance of pretreatment 18F-fluorodeoxyglucose positron emission tomography evaluation using metabolic tumor volume of the primary tumor and lymph nodes in advanced hypopharyngeal cancer. Head Neck 2019;41:739-47. [PMID: 30536887 DOI: 10.1002/hed.25429] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
26 Castelli J, Depeursinge A, Devillers A, Campillo-gimenez B, Dicente Y, Prior JO, Chajon E, Jegoux F, Sire C, Acosta O, Gherga E, Sun X, De Bari B, Bourhis J, de Crevoisier R. PET-based prognostic survival model after radiotherapy for head and neck cancer. Eur J Nucl Med Mol Imaging 2019;46:638-49. [DOI: 10.1007/s00259-018-4134-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
27 Gupta A. Supraglottic Laryngeal Cancer. PET/MR Imaging 2018. [DOI: 10.1007/978-3-319-65106-4_107] [Reference Citation Analysis]
28 Morales MN, Ramirez AM, Glez JPO, Espinosa CG, González JG, Marín CFC, Cepero WQ, Reina FL, Mora RE. PET/CT and Hypo-Fractionated Radiotherapy of Patients with Head and Neck Cancer. IJCM 2018;09:751-759. [DOI: 10.4236/ijcm.2018.910062] [Reference Citation Analysis]
29 Squamous Cell Carcinoma. Specialty Imaging: PET 2018. [DOI: 10.1016/b978-0-323-52484-1.50040-6] [Reference Citation Analysis]
30 Teng F, Aryal M, Lee J, Lee C, Shen X, Hawkins PG, Mierzwa M, Eisbruch A, Cao Y. Adaptive Boost Target Definition in High-Risk Head and Neck Cancer Based on Multi-imaging Risk Biomarkers. Int J Radiat Oncol Biol Phys 2018;102:969-77. [PMID: 29428251 DOI: 10.1016/j.ijrobp.2017.12.269] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
31 Castelli J, Depeursinge A, de Bari B, Devillers A, de Crevoisier R, Bourhis J, Prior JO. Metabolic Tumor Volume and Total Lesion Glycolysis in Oropharyngeal Cancer Treated With Definitive Radiotherapy: Which Threshold Is the Best Predictor of Local Control? Clin Nucl Med 2017;42:e281-5. [PMID: 28288042 DOI: 10.1097/RLU.0000000000001614] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
32 Kale H, Rath TJ. Chapter 3 The Role of PET/CT in Squamous Cell Carcinoma of the Head and Neck. Semin Ultrasound CT MR 2017;38:479-94. [PMID: 29031365 DOI: 10.1053/j.sult.2017.06.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
33 Cacicedo J, Fernandez I, Del Hoyo O, Navarro A, Gomez-Iturriaga A, Pijoan JI, Martinez-Indart L, Escudero J, Gomez-Suarez J, de Zarate RO, Perez JF, Bilbao P, Rades D. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma. Clin Transl Oncol 2017;19:1337-49. [PMID: 28540535 DOI: 10.1007/s12094-017-1674-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
34 Castelli J, Depeursinge A, Ndoh V, Prior JO, Ozsahin M, Devillers A, Bouchaab H, Chajon E, de Crevoisier R, Scher N, Jegoux F, Laguerre B, De Bari B, Bourhis J. A PET-based nomogram for oropharyngeal cancers. Eur J Cancer 2017;75:222-30. [PMID: 28237868 DOI: 10.1016/j.ejca.2017.01.018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
35 Castelli J, De Bari B, Depeursinge A, Simon A, Devillers A, Roman Jimenez G, Prior J, Ozsahin M, de Crevoisier R, Bourhis J. Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy. Crit Rev Oncol Hematol 2016;108:40-51. [PMID: 27931839 DOI: 10.1016/j.critrevonc.2016.10.009] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]